Clinical Trial Update: Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating regorafenib alone or in combination with hypofractionated/low-dose radiotherapy plus toripalimab for microsatellite-stabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Microsatellite Stable Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING